News
AAPG ▼ -2.7% - Ascentage Pharma Group Internat
AAPG ▼ -2.7% - Ascentage Pharma Group Internat
$AAPG - Ascentage Pharma Announces Inclusion of Lisaftoclax in China's 2026 National Reimbursement Drug List and Successful Renewal of Coverage for Olverembatinib
15-NOV-2026 06:30 PM ET
Share this post
More filings for $AAPG
AAPG ▲ +11.8% - Ascentage Pharma Group InternatNov 4, 2026AAPG ▲ +0.1% - Ascentage Pharma Group InternatNov 3, 2026AAPG ▲ +3.6% - Ascentage Pharma Group InternatOct 20, 2026AAPG ▼ -1.1% - Ascentage Pharma Group InternatSep 2, 2026
View full $AAPG filing history →💬 Comments
Loading comments…
Leave a comment